These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16499220)

  • 1. [Catecholaminergic polymorphic ventricular tachycardia successfully treated by beta blocker].
    Hayashi M; Okazaki H; Igei S; Inada K; Matuo S; Date T; Yagi H; Yamane T; Sugimoto K; Mochizuki S
    Nihon Naika Gakkai Zasshi; 2006 Jan; 95(1):136-9. PubMed ID: 16499220
    [No Abstract]   [Full Text] [Related]  

  • 2. Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol.
    De Rosa G; Delogu AB; Piastra M; Chiaretti A; Bloise R; Priori SG
    Pediatr Emerg Care; 2004 Mar; 20(3):175-177. PubMed ID: 15094576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent?
    Ackerman MJ; Priori SG; Dubin AM; Kowey P; Linker NJ; Slotwiner D; Triedman J; Van Hare GF; Gold MR
    Heart Rhythm; 2017 Jan; 14(1):e41-e44. PubMed ID: 27659101
    [No Abstract]   [Full Text] [Related]  

  • 4. [Catecholaminergic polymorphic ventricular tachycardia in a child: an often unrecognized diagnosis].
    Massin M; Leroy P; Misson JP; Lepage P
    Arch Pediatr; 2003 Jun; 10(6):524-6. PubMed ID: 12915016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.
    Eldar M; Pras E; Lahat H
    Cold Spring Harb Symp Quant Biol; 2002; 67():333-7. PubMed ID: 12858557
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing.
    Fisher JD; Krikler D; Hallidie-Smith KA
    J Am Coll Cardiol; 1999 Dec; 34(7):2015-22. PubMed ID: 10588218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-induced polymorphic ventricular tachycardia in adults without structural heart disease.
    Tan JH; Scheinman MM
    Am J Cardiol; 2008 Apr; 101(8):1142-6. PubMed ID: 18394448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catecholaminergic polymorphic ventricular tachycardia with associated sinus node dysfunction.
    Joshi P; Saxena A; Kaul U; Mansoor AH
    Indian Heart J; 2010; 62(1):84-6. PubMed ID: 21180045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.
    Kannankeril PJ; Moore JP; Cerrone M; Priori SG; Kertesz NJ; Ro PS; Batra AS; Kaufman ES; Fairbrother DL; Saarel EV; Etheridge SP; Kanter RJ; Carboni MP; Dzurik MV; Fountain D; Chen H; Ely EW; Roden DM; Knollmann BC
    JAMA Cardiol; 2017 Jul; 2(7):759-766. PubMed ID: 28492868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise-provoked bidirectional ventricular tachycardia in a young woman.
    Lin YH; Lai LP; Lin TK; Lin JL
    J Formos Med Assoc; 2004 Oct; 103(10):780-3. PubMed ID: 15490029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
    Rosso R; Kalman JM; Rogowski O; Diamant S; Birger A; Biner S; Belhassen B; Viskin S
    Heart Rhythm; 2007 Sep; 4(9):1149-54. PubMed ID: 17765612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.
    Haugaa KH; Leren IS; Berge KE; Bathen J; Loennechen JP; Anfinsen OG; Früh A; Edvardsen T; Kongsgård E; Leren TP; Amlie JP
    Europace; 2010 Mar; 12(3):417-23. PubMed ID: 20106799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of asymptomatic catecholaminergic polymorphic ventricular tachycardia.
    Obeyesekere MN; Sy RW; Leong-Sit P; Gula LJ; Yee R; Skanes AC; Klein GJ; Krahn AD
    Future Cardiol; 2012 May; 8(3):439-50. PubMed ID: 22642633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
    Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM; Fischbach PS; Wagner MB; Xu C
    Dis Model Mech; 2016 Sep; 9(9):927-39. PubMed ID: 27491078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U-waves and T-wave peak to T-wave end intervals in patients with catecholaminergic polymorphic ventricular tachycardia, effects of beta-blockers.
    Viitasalo M; Oikarinen L; Väänänen H; Kontula K; Toivonen L; Swan H
    Heart Rhythm; 2008 Oct; 5(10):1382-8. PubMed ID: 18929323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation in the RYR2 gene leading to catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation: dose-dependent arrhythmia-event suppression by β-blocker therapy.
    Kazemian P; Gollob MH; Pantano A; Oudit GY
    Can J Cardiol; 2011; 27(6):870.e7-10. PubMed ID: 21652165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical assessment of adrenergic tone and responsiveness to beta-blocker therapy in patients with symptomatic ventricular tachycardia and no apparent structural heart disease.
    Brodsky MA; Orlov MV; Allen BJ; Orlov YS; Wolff L; Winters R
    Am Heart J; 1996 Jan; 131(1):51-8. PubMed ID: 8554019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocker treatment of caffeine-induced tachydysrhythmias.
    Richards JR; Ramoska EA; Sand IC
    Clin Toxicol (Phila); 2016 Jun; 54(5):466. PubMed ID: 27005475
    [No Abstract]   [Full Text] [Related]  

  • 19. Fetal ventricular tachycardia: betablockers should be the first line treatment.
    Vaksmann G; Lucidarme S; Henriet E
    J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101946. PubMed ID: 33068771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long term course of catecholaminergic polymorphic ventricular tachycardia in children. Apropos of 20 cases with an 8 year-follow-up].
    Lucet V; Grau F; Denjoy I; Do Ngoc D; Geiger K; Ghisla R; Mselati JC; Leenhardt A; Coumel P
    Arch Pediatr; 1994 Jan; 1(1):26-32. PubMed ID: 7916243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.